Biocompatibility of Fe(3)O(4) nanoparticles evaluated by in vitro cytotoxicity assays using normal, glia and breast cancer cells.
about
Phytochemicals and Biogenic Metallic Nanoparticles as Anticancer AgentsToxicological evaluation of dextran stabilized iron oxide nanoparticles in human peripheral blood lymphocytesPotential toxicity of superparamagnetic iron oxide nanoparticles (SPION)Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.Smart electrospun nanofibers for controlled drug release: recent advances and new perspectivesFacile synthesis of folate-conjugated magnetic/fluorescent bifunctional microspheres.Inorganic-organic hybrid nanomaterials for therapeutic and diagnostic imaging applications.Inhibitory effect of magnetic Fe3O4 nanoparticles coloaded with homoharringtonine on human leukemia cells in vivo and in vitro.Iron oxide nanoparticles suppress the production of IL-1beta via the secretory lysosomal pathway in murine microglial cellsSustained release of prindopril erbumine from its chitosan-coated magnetic nanoparticles for biomedical applications.Metallic nanoparticles and their medicinal potential. Part II: aluminosilicates, nanobiomagnets, quantum dots and cochleates.Integrated graphene/nanoparticle hybrids for biological and electronic applications.Applications of magnetosomes synthesized by magnetotactic bacteria in medicine.Photo-fluorescent and magnetic properties of iron oxide nanoparticles for biomedical applications.Biofunctional Materials Based on Amino Cellulose Derivatives--A Nanobiotechnological Concept.Preparation and characterization of 6-mercaptopurine-coated magnetite nanoparticles as a drug delivery systemAnti-CEA loaded maghemite nanoparticles as a theragnostic device for colorectal cancer.The synthesis and characterization of monodispersed chitosan-coated Fe3O4 nanoparticles via a facile one-step solvothermal process for adsorption of bovine serum albumin.Iron oxide magnetic nanoparticles combined with actein suppress non-small-cell lung cancer growth in a p53-dependent manner.A comparative study on the in vitro cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles.A Comparative Study of Receptor-Targeted Magnetosome and HSA-Coated Iron Oxide Nanoparticles as MRI Contrast-Enhancing Agent in Animal Cancer Model.Enhanced killing of HepG2 during cryosurgery with Fe3O4-nanoparticle improved intracellular ice formation and cell dehydration.Synthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications.Comprehensive cytotoxicity studies of superparamagnetic iron oxide nanoparticles.Iron-loaded PLLA nanoparticles as highly efficient intracellular markers for visualization of mesenchymal stromal cells by MRI.Biosynthesis, characterization of magnetic iron oxide nanoparticles and evaluations of the cytotoxicity and DNA damage of human breast carcinoma cell lines.Release behavior and toxicity profiles towards leukemia (WEHI-3B) cell lines of 6-mercaptopurine-PEG-coated magnetite nanoparticles delivery system.Enhanced Homing Technique of Mesenchymal Stem Cells Using Iron Oxide Nanoparticles by Magnetic Attraction in Olfactory-Injured Mouse Models.Shape-, size- and structure-controlled synthesis and biocompatibility of iron oxide nanoparticles for magnetic theranostics.In vitroandin vivoexperiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: Magnetic targetingDesign, synthesis, characterisation and in vitro studies of hydrophilic, colloidally stable, 64Cu(ii)-labelled, ultra-small iron oxide nanoparticles in a range of human cell linesThermosensitivity profile of malignant glioma U87-MG cells and human endothelial cells following γ-Fe2O3 NPs internalization and magnetic field applicationAn in vitro analysis of H1N1 viral inhibition using polymer coated superparamagnetic Fe3O4 nanoparticlesPreparation of iron oxide nanoparticles by laser ablation in DMF under effect of external magnetic field
P2860
Q26750806-B9F44D75-BEDE-4493-B7A1-4A8B549F4DCDQ28390035-1E23A73B-4C51-4D64-8190-71758F90FB5CQ28393651-B6E3F4CD-1D8A-4690-BBD7-102148EFE263Q30827270-586D09C8-C052-478E-80EB-350D32D114DCQ33857874-DD175097-51C0-4B01-AE88-6464B2F1B51DQ34352538-9A2DFF1F-8113-479B-833A-9738C419DC19Q35091821-74A88048-F12F-48BB-B0CF-858DD4F695D3Q37248812-B585DBC7-1AF5-4D02-A8CF-58EBB7136767Q37364239-E163BDFA-A625-4BC1-91F7-80859940BDDEQ37420871-2A319DF1-CA6B-4230-9B83-3C508256DC0AQ38136245-234E9962-0F90-4378-A5BF-C523E85B0BF9Q38206112-4E5B4A77-F435-4E82-89C6-65B084F4BCC2Q38242829-31752BC8-8D08-4C96-BE92-E26D1A1BAD69Q38433641-AFEA454D-B865-4AAC-98C8-CC40A82688A1Q38557909-D65382A5-993E-4EF4-AF5C-E50EF62EE922Q39084200-5348BE73-EFF3-465F-A0D8-CD9CF26BA36DQ39261689-8D91ED3B-2600-4510-8BC5-3A7B269E21E2Q41157315-F5CFC098-569B-47B7-8008-5CEE79D099A3Q43716591-E7B2EDDF-7ED2-46F6-9B64-210B0A58FEB9Q46515323-200AB6C0-F6C1-4DD2-8CB1-8E59A7212E03Q46644294-21F3AC8E-1CC3-4B1A-8F89-4324BD391D4FQ47107013-CBD7B971-9854-434F-8248-DAF2F515F00DQ47589446-B41AE61D-1931-4CF9-84A3-FD1DBFA32CECQ49438313-FB8CEDDC-94B8-484F-BC1E-8D405401A302Q50623027-3E99EEA8-C215-40BD-A9F0-A55BED93E08DQ52758417-A4978C16-F2D0-441E-A0B7-AAD41392ABE0Q54974928-61D9543D-839E-43AD-9095-B97D44D60A09Q55255305-FCE24B49-F589-4E52-BF70-F7F6BC75DD16Q55450179-5B7AAE86-EA10-4E78-B341-2D6E0C22BB2EQ57348922-8BC2A262-57F5-45A0-BA4E-649E0F5AD3A5Q57376692-1FA26169-7732-4708-B8C0-1A792DFE8FA4Q57559243-11E80A46-6E36-4C9E-8A40-1D29C803BE68Q58376680-AD605213-DB65-48D7-96A9-E41B96097074Q58642821-D7131129-9F72-40CB-859B-27C8AF40A3E5
P2860
Biocompatibility of Fe(3)O(4) nanoparticles evaluated by in vitro cytotoxicity assays using normal, glia and breast cancer cells.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Biocompatibility of Fe(3)O(4) ...... glia and breast cancer cells.
@en
Biocompatibility of Fe(3)O(4) ...... glia and breast cancer cells.
@nl
type
label
Biocompatibility of Fe(3)O(4) ...... glia and breast cancer cells.
@en
Biocompatibility of Fe(3)O(4) ...... glia and breast cancer cells.
@nl
prefLabel
Biocompatibility of Fe(3)O(4) ...... glia and breast cancer cells.
@en
Biocompatibility of Fe(3)O(4) ...... glia and breast cancer cells.
@nl
P2093
P921
P356
P1433
P1476
Biocompatibility of Fe(3)O(4) ...... glia and breast cancer cells.
@en
P2093
P356
10.1088/0957-4484/21/7/075102
P577
2010-01-21T00:00:00Z